Role of STAT3 and FOXO1 in the Divergent Therapeutic Responses of Non-metastatic and Metastatic Bladder Cancer Cells to miR-145

Guosong Jiang(Union Hospital), Junlan Zhu(New York University), Xue‐Ru Wu(Chongqing Medical University), Honglei Jin(Wenzhou Medical University), Chao Huang(Nanchang University), Haishan Huang(Wenzhou Medical University), Chuanshu Huang(Wenzhou Medical University), Jingxia Li(Wenzhou Medical University)
Molecular Cancer Therapeutics
February 22, 2017
Cited by 39


Related Papers